A Peripheral Blood DNA Methylation Signature of Hepatic Fat Reveals a Potential Causal Pathway for Non-Alcoholic Fatty Liver Disease

Diabetes - United States
doi 10.2337/db18-1193
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

Systems Genetics of Hepatic Metabolome Reveals Octopamine as a Target for Non-Alcoholic Fatty Liver Disease Treatment

Scientific Reports
Multidisciplinary
2019English

Monounsaturated Fat Decreases Hepatic Lipid Content in Non-Alcoholic Fatty Liver Disease in Rats

World Journal of Gastroenterology
MedicineGastroenterology
2007English

The Role of Hepatic Fat Accumulation in Pathogenesis of Non-Alcoholic Fatty Liver Disease (NAFLD)

Lipids in Health and Disease
BiochemistryEndocrinologyClinical BiochemistryMetabolismDiabetes
2010English

Epicardial Fat in Patients With Non-Alcoholic Fatty Liver Disease

Journal of Hepatology
Hepatology
2015English

Mechanism of Hepatic Insulin Resistance in Non-Alcoholic Fatty Liver Disease

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2004English

Treatment of Non-Alcoholic Fatty Liver Disease

Postgraduate Medical Journal
Medicine
2006English

Non-Alcoholic Fatty Liver Disease and Disease Mongering

American Journal of Medicine
Medicine
2019English

Ad Libitum Mediterranean or Low Fat Diets as Treatments for Non-Alcoholic Fatty Liver Disease?

Hepatology
MedicineHepatology
2018English

Diagnosis of Non-Alcoholic Fatty Liver Disease (NAFLD)

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy